Infliximab for refractory ulcerative colitis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 • 3,152 citations
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 • 2,656 citations
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
1994 • 1,694 citations
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
1995 • 1,103 citations
Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and Safety
1999 • 459 citations
Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis
1997 • 254 citations
Specific antibody response to oligomannosidic epitopes in Crohn's disease
1996 • 238 citations
Hapten-induced Colitis Is Associated with Colonic Patch Hypertrophy and T Helper Cell 2–Type Responses
1999 • 177 citations
Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.
1990 • 177 citations
Association of Antineutrophil Cytoplasmic Antibodies With Resistance to Treatment of Left-Sided Ulcerative Colitis: Results of a Pilot Study
1996 • 139 citations
Treatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571
1997 • 133 citations
Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients.
1995 • 113 citations
Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.
1997 • 97 citations
Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease
1996 • 83 citations
The Effect of Dietary Yeast on the Activity of Stable Chronic Crohn's Disease
1992 • 76 citations
Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis
1997 • 58 citations